ArticleCancers2023

Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.

Peter H J Slootbeek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.